Description

Participant enrollment and randomization flow for the double-blind trial evaluating α-galactosidase in children with gas-related symptoms is depicted.

More Figures from This Paper

Figure 2

Frequency of gas-related episodes is compared between children receiving α-galactosidase and placebo over the treatment period, indicating changes in symptom burden.

chart

Figure 3

Overall symptom severity scores for gas-related complaints in children are tracked across the study timeline, comparing the α-galactosidase and placebo arms.

chart

Figure 1

Flowchart

430 × 224px · 29.6 KB

Source Paper

Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial.

BMC gastroenterology (2013)

PMID: 24063420

DOI: 10.1186/1471-230X-13-142

Cite This Figure

![Figure 1: Participant enrollment and randomization flow for the double-blind trial evaluating α-galactosidase in children with gas-related symptoms is depicted.](https://pdfs.citedhealth.com/figures/24063420/54.png)

> Source: Giovanni Di Nardo et al. "Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in." *BMC gastroenterology*, 2013. PMID: [24063420](https://pubmed.ncbi.nlm.nih.gov/24063420/)

<figure>
  <img src="https://pdfs.citedhealth.com/figures/24063420/54.png" alt="Participant enrollment and randomization flow for the double-blind trial evaluating α-galactosidase in children with gas-related symptoms is depicted." />
  <figcaption>Figure 1. Participant enrollment and randomization flow for the double-blind trial evaluating α-galactosidase in children with gas-related symptoms is depicted.<br>  Source: Giovanni Di Nardo et al. "Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in." <em>BMC gastroenterology</em>, 2013. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/24063420/">24063420</a></figcaption>
</figure>

Related Evidence

Alpha-Galactosidase for Bloating and Intestinal Gas

Grade B · 4 studies